0
Skip to Content
No Patient Left Behind
About Us
What We Believe
Who We Are
Our Team
Advisory Councils
Life Science Builders
Policy
Value of Medicines
Protect Innovation
Fix Insurance
Most Favored Nation
All Letters
Learn
Fundamentals
Featured Materials
Resource library
chat-NPLB
WEBINAR: Out-of-Pocket Costs
Get Involved
NPLB Fellowship
Patient Stories
Become a First Responder
Community Quests
News
Press releases
Media
Blog
Search
Donate
No Patient Left Behind
About Us
What We Believe
Who We Are
Our Team
Advisory Councils
Life Science Builders
Policy
Value of Medicines
Protect Innovation
Fix Insurance
Most Favored Nation
All Letters
Learn
Fundamentals
Featured Materials
Resource library
chat-NPLB
WEBINAR: Out-of-Pocket Costs
Get Involved
NPLB Fellowship
Patient Stories
Become a First Responder
Community Quests
News
Press releases
Media
Blog
Search
Donate
Folder: About Us
Back
What We Believe
Who We Are
Our Team
Advisory Councils
Life Science Builders
Folder: Policy
Back
Value of Medicines
Protect Innovation
Fix Insurance
Most Favored Nation
All Letters
Folder: Learn
Back
Fundamentals
Featured Materials
Resource library
chat-NPLB
WEBINAR: Out-of-Pocket Costs
Folder: Get Involved
Back
NPLB Fellowship
Patient Stories
Become a First Responder
Community Quests
Folder: News
Back
Press releases
Media
Blog
Search
Donate
5 ways Biden’s SOTU could advance biotech affordability and innovation
Blog Post Marshall Bursis 3/5/24 Blog Post Marshall Bursis 3/5/24

5 ways Biden’s SOTU could advance biotech affordability and innovation

Here are five policies President Biden should include in his State of the Union address on Thursday.

Read More
Measuring the damage: IRA’s impact on small molecule drug development
Blog Post Marshall Bursis 3/31/23 Blog Post Marshall Bursis 3/31/23

Measuring the damage: IRA’s impact on small molecule drug development

Read what one oncology executive discovered when he surveyed the biotech community.

Read More
PBMs: The Secretive Middlemen for Insurance and Drug Companies
Blog Post Marshall Bursis 12/25/20 Blog Post Marshall Bursis 12/25/20

PBMs: The Secretive Middlemen for Insurance and Drug Companies

Read More

About Us

What We Believe
Who We Are
Our Team
Advisory Councils

Policy

Value of Medicines (GCEA)
Small Molecule Parity
Fixing Insurance

Resources

Presentations
Animations & Videos
Research
Advocacy

In the News

Press Releases
Media Coverage
Blog


Copyright, No Patient Left Behind 2023 | A Mission Edge Project

Privacy Policy
Cookie Policy
/* Autoscroll fix */